IDEAYA Biosciences (IDYA) Stock Chart & Stock Price History → Bill Clinton Backing Biden Replacement??? (From The Freeport Society) (Ad) Free IDYA Stock Alerts $37.58 -0.75 (-1.96%) (As of 06/11/2024 ET) Add Compare Share Share ChartStock AnalysisAnalyst ForecastsChartCompetitorsEarningsFinancialsHeadlinesInsider TradesOptions ChainOwnershipSEC FilingsShort InterestSustainabilityTrendsStock AnalysisAnalyst ForecastsChartCompetitorsEarningsFinancialsHeadlinesInsider TradesOptions ChainOwnershipSEC FilingsShort InterestSustainabilityTrends IDEAYA Biosciences Stock Price Performance5 Day Performance-5.17%1 Month Performance-8.72%3 Month Performance-13.77%6 Month Performance+19.30%Year-To-Date Performance+5.62%1 Year Performance+47.49% Receive IDYA Stock News and Ratings via Email Sign-up to receive the latest news and ratings for IDEAYA Biosciences and its competitors with MarketBeat's FREE daily newsletter Email Address Ad Stansberry ResearchWall Street Icon: "I'd Put 50% of My Kids' Inheritance in THIS stock"Wall Street Icon Warns: "A Great Financial Reset is Underway" The man CNBC called "The Prophet" predicted the 2008 housing crisis and the 2022 sell-off… Now, he says that despite the bull market, he's worried older Americans are holding the WRONG stocks in their portfolios for this stage of their lives. So, he's urging folks to buy "America's No. 1 Legacy Stock," which could help them build wealth they could pass on for generations.Learn more here. IDYA Stock Chart for Wednesday, June, 12, 2024 IDYA Chart by TradingView IDEAYA Biosciences Share Price History Daily Weekly Monthly Time Frame Custom Range 1 Month 3 Months 6 Months Year-to-Date 1 Year Time Frame * Start Date * End Date Export to Excel DateOpening PriceClosing PriceHighLowVolumeMarket Capitalization06/11/2024$38.33$37.58-1.96%$38.31$36.85606,705 shs$2.84 billion06/10/2024$38.01$38.33+0.84%$38.74$37.27914,620 shs$2.90 billion06/07/2024$39.63$38.01-4.09%$39.44$37.39825,896 shs$2.88 billion06/06/2024$39.66$39.63-0.08%$39.97$38.76497,699 shs$3.00 billion06/05/2024$38.61$39.66+2.72%$39.92$38.67878,207 shs$3.00 billion06/04/2024$38.89$38.61-0.72%$40.10$38.471.04 million shs$2.92 billion Get the Latest News and Ratings for IDYA and Related StocksEnter your email address below to receive the latest news and analysts' ratings for IDEAYA Biosciences and its competitors with MarketBeat's FREE daily newsletter. 06/03/2024$36.55$38.89+6.40%$40.08$36.771.15 million shs$2.94 billion05/31/2024$35.79$36.55+2.12%$37.41$35.87973,584 shs$2.77 billion05/30/2024$35.91$35.79-0.33%$36.48$35.58903,042 shs$2.71 billion05/29/2024$37.53$35.91-4.32%$37.23$35.571.15 million shs$2.72 billion05/28/2024$37.71$37.53-0.48%$38.35$35.951.53 million shs$2.84 billion05/27/2024$37.71$37.71$40.40$37.442.13 million shs$2.85 billion05/24/2024$38.45$37.71-1.92%$40.40$37.442.13 million shs$2.85 billion05/23/2024$41.38$38.45-7.08%$41.58$38.231.00 million shs$2.91 billion05/22/2024$41.00$41.38+0.93%$41.79$39.991.28 million shs$3.13 billion05/21/2024$40.32$41.00+1.69%$42.20$39.901.51 million shs$3.10 billion05/20/2024$40.50$40.32-0.44%$41.29$40.30596,585 shs$3.05 billion05/17/2024$41.53$40.50-2.48%$41.25$40.02761,255 shs$3.07 billion05/16/2024$42.44$41.53-2.14%$42.82$41.21532,228 shs$3.14 billion05/15/2024$41.80$42.44+1.53%$44.15$42.10762,107 shs$3.21 billion05/14/2024$41.07$41.80+1.78%$41.95$40.76373,266 shs$3.16 billion05/13/2024$41.17$41.07-0.24%$41.61$40.89361,924 shs$3.11 billion05/10/2024$40.64$41.17+1.30%$41.23$40.00446,904 shs$3.08 billion05/09/2024$41.41$40.64-1.86%$41.52$40.48406,388 shs$3.04 billion05/08/2024$42.75$41.41-3.13%$42.37$40.57550,931 shs$3.10 billion05/07/2024$43.09$42.75-0.79%$43.81$41.71933,334 shs$3.20 billion05/06/2024$42.18$43.09+2.16%$43.29$41.78435,280 shs$3.22 billion05/03/2024$41.49$42.18+1.66%$43.00$42.00356,005 shs$3.15 billion05/02/2024$41.18$41.49+0.75%$42.04$40.91472,995 shs$3.10 billion05/01/2024$40.65$41.18+1.30%$42.45$40.461.13 million shs$3.08 billion04/30/2024$40.65$40.65$41.22$39.98724,351 shs$3.04 billion04/29/2024$39.94$40.65+1.78%$41.38$39.98636,155 shs$3.04 billion04/26/2024$38.62$39.94+3.42%$40.36$38.11619,378 shs$2.99 billion04/25/2024$39.85$38.62-3.09%$39.93$37.81734,655 shs$2.89 billion04/24/2024$39.02$39.85+2.13%$40.31$38.961.37 million shs$2.98 billion04/23/2024$37.59$39.02+3.80%$39.53$38.00486,181 shs$2.91 billion04/22/2024$37.13$37.59+1.24%$38.52$36.85784,204 shs$2.80 billion04/19/2024$37.62$37.13-1.30%$38.30$36.58726,137 shs$2.77 billion04/18/2024$40.17$37.62-6.35%$40.17$37.51817,564 shs$2.80 billion04/17/2024$41.17$40.17-2.43%$41.45$39.81496,442 shs$3.00 billionWall Street Icon: "I'd Put 50% of My Kids' Inheritance in THIS stock" (Ad)Wall Street Icon Warns: "A Great Financial Reset is Underway" The man CNBC called "The Prophet" predicted the 2008 housing crisis and the 2022 sell-off… Now, he says that despite the bull market, he's worried older Americans are holding the WRONG stocks in their portfolios for this stage of their lives. So, he's urging folks to buy "America's No. 1 Legacy Stock," which could help them build wealth they could pass on for generations.Learn more here.04/16/2024$41.51$41.17-0.82%$42.02$41.05404,934 shs$3.07 billion04/15/2024$41.97$41.51-1.10%$42.68$40.97339,862 shs$3.09 billion04/12/2024$43.46$41.97-3.43%$43.84$41.29400,736 shs$3.13 billion04/11/2024$42.30$43.46+2.74%$43.60$42.36533,839 shs$3.24 billion04/10/2024$42.57$42.30-0.63%$42.42$41.10532,593 shs$3.15 billion04/09/2024$41.99$42.57+1.38%$42.71$41.70579,379 shs$3.17 billion04/08/2024$42.51$41.99-1.22%$43.03$41.43477,589 shs$3.13 billion04/05/2024$41.40$42.51+2.68%$42.65$40.70386,130 shs$3.17 billion04/04/2024$42.15$41.40-1.78%$43.03$41.21396,604 shs$3.09 billion04/03/2024$41.50$42.15+1.57%$42.16$40.95482,759 shs$3.14 billion04/02/2024$42.52$41.50-2.40%$42.72$41.35661,611 shs$3.09 billion04/01/2024$43.88$42.52-3.10%$44.25$42.37636,366 shs$3.17 billion03/29/2024$43.88$43.88$44.17$42.84729,125 shs$3.27 billion03/28/2024$43.31$43.88+1.32%$44.17$42.84729,125 shs$3.27 billion03/27/2024$42.51$43.31+1.88%$43.55$42.54480,456 shs$3.23 billion03/26/2024$42.31$42.51+0.47%$43.23$42.13695,738 shs$3.17 billion03/25/2024$43.03$42.31-1.67%$43.69$42.22563,764 shs$3.15 billion03/22/2024$45.63$43.03-5.70%$45.32$42.99582,968 shs$3.21 billion03/21/2024$44.81$45.63+1.83%$46.40$45.23967,356 shs$3.40 billion03/20/2024$44.31$44.81+1.13%$44.89$42.71633,630 shs$3.34 billion03/19/2024$43.46$44.31+1.96%$45.30$42.83704,684 shs$3.30 billion03/18/2024$44.30$43.46-1.90%$44.44$43.21889,037 shs$3.24 billion03/15/2024$44.80$44.30-1.12%$45.41$43.842.11 million shs$3.30 billion03/14/2024$45.71$44.80-1.99%$45.93$43.96832,185 shs$3.34 billion03/13/2024$44.76$45.71+2.12%$45.77$44.44535,234 shs$3.41 billion03/12/2024$43.58$44.76+2.71%$46.07$43.00597,520 shs$3.34 billion03/11/2024$45.56$43.58-4.35%$45.66$43.44677,259 shs$3.25 billion Related Companies: Catalyst Pharmaceuticals Stock Price Chart Syros Pharmaceuticals Stock Price Chart Cue Biopharma Stock Price Chart Dr. Reddy's Laboratories Stock Price Chart Sarepta Therapeutics Stock Price Chart Catalent Stock Price Chart Elanco Animal Health Stock Price Chart Roivant Sciences Stock Price Chart Insmed Stock Price Chart Ascendis Pharma A/S Stock Price Chart Receive IDYA Stock News and Ratings via EmailSign-up to receive the latest news and ratings for IDEAYA Biosciences and its competitors with MarketBeat's FREE daily newsletter. This page (NASDAQ:IDYA) was last updated on 6/12/2024 by MarketBeat.com Staff From Our PartnersYour Special Report - Top 7 Summer StocksSummer is almost Here! I would like to give you a special report that could help boost your portfolio this sum...StockEarnings | SponsoredAI's Next Magnificent SevenThe Original Magnificent Seven Produced 16,894% Average Returns Over 20 Years.The Oxford Club | SponsoredWe recommended Nvidia in 2016, now we’re recommending this…The AI boom is just getting started. And the real wealth has still to be made…Porter & Company | SponsoredThe Hidden Tax Advantages of America’s #1 Inheritance StockWall Street Millionaire: BUY "America's #1 Legacy Stock" The man CNBC called "The Prophet" bought AAPL at $...Stansberry Research | SponsoredBill Clinton Backing Biden Replacement???Louis Navellier — a frequent guest at Mar-a-Lago — ruffled many in his own circles when he declared over a yea...The Freeport Society | SponsoredTop 5 Tech Stocks to Buy for 2024The next evolution of technology is already upending industries worth $7 Trillion… It's already got the world'...Daily Market Alerts | SponsoredTop 5 AI Stocks to Buy for 2024The electric vehicle boom is accelerating – and fast.Market Moving Trends | SponsoredNo Strings Attached: Get 30 Days of Hedgeye’s Top Stock Picks for FreeOptimize your stock investing strategy with Hedgeye's Investing Ideas, where rigorous fundamental stock analys...Hedgeye | Sponsored Adding Choose a watchlist: Watchlist Adding You have already added five stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding IDEAYA Biosciences, Inc. Please log in to your account or sign up in order to add this asset to your watchlist. Share IDEAYA Biosciences With A Colleague Link copied to clipboard. Get 30 Days of MarketBeat All Access for Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools. Start Your 30-Day Trial MarketBeat All Access Features Best-in-Class Portfolio Monitoring Get personalized stock ideas. Compare portfolio to indices. Check stock news, ratings, SEC filings, and more. Stock Ideas and Recommendations See daily stock ideas from top analysts. Receive short-term trading ideas from MarketBeat. Identify trending stocks on social media. Advanced Stock Screeners and Research Tools Use our seven stock screeners to find suitable stocks. Stay informed with MarketBeat's real-time news. Export data to Excel for personal analysis. Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.